Related Experiment Videos
[Concomitant radiochemotherapy for non-small-cell lung cancer: towards an ideal strategy]
Revue Des Maladies Respiratoires
|September 8, 2001
Abstract
No abstract available in PubMed .
Related Concept Videos
Articles linked to this work by shared authors, journal, and citation graph.
A phase 1 study of vinflunine in combination with trastuzumab for the treatment for HER2-positive metastatic breast cancer.
Cancer chemotherapy and pharmacology·2012
Negative impact of bone metastasis on outcome in clear-cell renal cell carcinoma treated with sunitinib.
Annals of oncology : official journal of the European Society for Medical Oncology·2010
[New therapeutics strategies in renal cell carcinoma].
Bulletin du cancer·2010
Targeted agents in metastatic Xp11 translocation/TFE3 gene fusion renal cell carcinoma (RCC): a report from the Juvenile RCC Network.
Annals of oncology : official journal of the European Society for Medical Oncology·2010
[Toward novel therapeutic strategies: Targeting the extracellular matrix to broaden the therapeutic window].
Revue des maladies respiratoires·2026
[Pathophysiology of pulmonary fibrosis associated with monogenic defects of telomere homeostasis].
Revue des maladies respiratoires·2026
[Pleural sarcoidosis: A diagnostic challenge in countries with high tuberculosis prevalence].
Revue des maladies respiratoires·2026
[Imaging of the diaphragm: A multimodal approach, and the role of MRI].
Revue des maladies respiratoires·2026
[The key role of chest CT in severe asthma phenotyping].
Revue des maladies respiratoires·2026
Feasibility of Single-Session Whole-Liver Yttrium-90 Radioembolization for Multifocal Hepatocellular Carcinoma.
Korean journal of radiology·2026
Cemiplimab in cutaneous squamous cell carcinoma: a longer follow-up study focusing on the late toxicities.
Journal der Deutschen Dermatologischen Gesellschaft = Journal of the German Society of Dermatology : JDDG·2026
Not all anti-CD38 antibodies are created equal: The epitope of felzartamab is partially DTT-resistant.
Transfusion medicine (Oxford, England)·2026